Cargando…

Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions

PURPOSE: Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. METHODS: SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dass, Sabrina E, Huizenga, Taryn, Farshchian, Mehdi, Mehregan, Darius R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502009/
https://www.ncbi.nlm.nih.gov/pubmed/34675577
http://dx.doi.org/10.2147/CCID.S333376
_version_ 1784580793713033216
author Dass, Sabrina E
Huizenga, Taryn
Farshchian, Mehdi
Mehregan, Darius R
author_facet Dass, Sabrina E
Huizenga, Taryn
Farshchian, Mehdi
Mehregan, Darius R
author_sort Dass, Sabrina E
collection PubMed
description PURPOSE: Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. METHODS: SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The total number of melanocytes stained with each immunohistochemical stain was counted and an average count was obtained from two readings. RESULTS: Analysis of the data revealed a significant difference in staining melanocytes between these three immunostains (p=0.0010, ANOVA). SOX-10 stained 0.195 more melanocytes than HMB-45 (p=0.0026). Similarly, Melan-A stained 0.195 more melanocytes than HMB-45 (p=0.0011). However, the difference between SOX-10 and Melan-A was not statistically significant (p=0.9810). CONCLUSION: SOX-10 and Melan-A immunostaining stain more melanocytes than HMB-45. No significant difference was noted between Melan-A and SOX-10.
format Online
Article
Text
id pubmed-8502009
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85020092021-10-20 Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions Dass, Sabrina E Huizenga, Taryn Farshchian, Mehdi Mehregan, Darius R Clin Cosmet Investig Dermatol Original Research PURPOSE: Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. METHODS: SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The total number of melanocytes stained with each immunohistochemical stain was counted and an average count was obtained from two readings. RESULTS: Analysis of the data revealed a significant difference in staining melanocytes between these three immunostains (p=0.0010, ANOVA). SOX-10 stained 0.195 more melanocytes than HMB-45 (p=0.0026). Similarly, Melan-A stained 0.195 more melanocytes than HMB-45 (p=0.0011). However, the difference between SOX-10 and Melan-A was not statistically significant (p=0.9810). CONCLUSION: SOX-10 and Melan-A immunostaining stain more melanocytes than HMB-45. No significant difference was noted between Melan-A and SOX-10. Dove 2021-10-05 /pmc/articles/PMC8502009/ /pubmed/34675577 http://dx.doi.org/10.2147/CCID.S333376 Text en © 2021 Dass et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Dass, Sabrina E
Huizenga, Taryn
Farshchian, Mehdi
Mehregan, Darius R
Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
title Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
title_full Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
title_fullStr Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
title_full_unstemmed Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
title_short Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
title_sort comparison of sox-10, hmb-45, and melan-a in benign melanocytic lesions
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502009/
https://www.ncbi.nlm.nih.gov/pubmed/34675577
http://dx.doi.org/10.2147/CCID.S333376
work_keys_str_mv AT dasssabrinae comparisonofsox10hmb45andmelanainbenignmelanocyticlesions
AT huizengataryn comparisonofsox10hmb45andmelanainbenignmelanocyticlesions
AT farshchianmehdi comparisonofsox10hmb45andmelanainbenignmelanocyticlesions
AT mehregandariusr comparisonofsox10hmb45andmelanainbenignmelanocyticlesions